Literature DB >> 19073418

What is the mechanism whereby cannabis use increases risk of psychosis?

Sonija Luzi1, Paul D Morrison, John Powell, Marta di Forti, Robin M Murray.   

Abstract

Cannabis use has increased greatly over the last three decades. The various types of cannabis differ in their concentration of the main psychoactive component, Delta-9-tetrahydrocannabinol (THC), and the other major ingredient, cannabidiol (CBD). Plant engineering has maximized levels of THC, thus increasing the potency of street cannabis. It is well known that cannabis intoxication can cause brief psychotic symptoms like paranoia, whilst recent evidence demonstrates that heavy use of cannabis increases the risk of chronic psychoses like schizophrenia; genetic vulnerability seems to predispose some people to a higher risk. This paper starts to consider the neurochemical mechanisms whereby cannabis use increases the risk of psychosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073418     DOI: 10.1007/BF03033802

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  53 in total

1.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

2.  Altering cannabinoid signaling during development disrupts neuronal activity.

Authors:  C Bernard; M Milh; Y M Morozov; Y Ben-Ari; T F Freund; H Gozlan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

3.  Hardwiring the brain: endocannabinoids shape neuronal connectivity.

Authors:  Paul Berghuis; Ann M Rajnicek; Yury M Morozov; Ruth A Ross; Jan Mulder; Gabriella M Urbán; Krisztina Monory; Giovanni Marsicano; Michela Matteoli; Alison Canty; Andrew J Irving; István Katona; Yuchio Yanagawa; Pasko Rakic; Beat Lutz; Ken Mackie; Tibor Harkany
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

4.  Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds.

Authors:  S L Leech; G A Richardson; L Goldschmidt; N L Day
Journal:  Neurotoxicol Teratol       Date:  1999 Mar-Apr       Impact factor: 3.763

5.  Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.

Authors:  Tiziana Antonelli; Maria Cristina Tomasini; Maria Tattoli; Tommaso Cassano; Sergio Tanganelli; Simone Finetti; Elisa Mazzoni; Luigia Trabace; Luca Steardo; Vincenzo Cuomo; Luca Ferraro
Journal:  Cereb Cortex       Date:  2005-03-23       Impact factor: 5.357

6.  Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor.

Authors:  Paul Berghuis; Marton B Dobszay; Xinyu Wang; Sabrina Spano; Fernanda Ledda; Kyle M Sousa; Gunnar Schulte; Patrik Ernfors; Ken Mackie; Gustavo Paratcha; Yasmin L Hurd; Tibor Harkany
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 7.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

8.  No association of CNR1 gene variations with susceptibility to schizophrenia.

Authors:  Jürgen Seifert; Sebastian Ossege; Hinderk M Emrich; Udo Schneider; Manfred Stuhrmann
Journal:  Neurosci Lett       Date:  2007-08-10       Impact factor: 3.046

Review 9.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

Review 10.  Endocannabinoid functions controlling neuronal specification during brain development.

Authors:  Tibor Harkany; Erik Keimpema; Klaudia Barabás; Jan Mulder
Journal:  Mol Cell Endocrinol       Date:  2008-03-04       Impact factor: 4.102

View more
  13 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Psychobiological responses to unpleasant emotions in cannabis users.

Authors:  Lorenzo Somaini; Matteo Manfredini; Mario Amore; Amir Zaimovic; Maria Augusta Raggi; Claudio Leonardi; Maria Lidia Gerra; Claudia Donnini; Gilberto Gerra
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-20       Impact factor: 5.270

5.  An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.

Authors:  Jonathan W Lovelace; Alex Corches; Philip A Vieira; Alex S Hiroto; Ken Mackie; Edward Korzus
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 6.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

7.  Failure to sustain prepulse inhibition in adolescent marijuana users.

Authors:  Charles W Mathias; Terry D Blumenthal; Michael A Dawes; Anthony Liguori; Dawn M Richard; Bethany Bray; Weiqun Tong; Donald M Dougherty
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

Review 8.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec

Review 9.  Epigenetic mediation of environmental influences in major psychotic disorders.

Authors:  Bart P F Rutten; Jonathan Mill
Journal:  Schizophr Bull       Date:  2009-09-25       Impact factor: 9.306

10.  Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Authors:  Ruth Salo; Catherine Fassbender; Ana-Maria Iosif; Stefan Ursu; Martin H Leamon; Cameron Carter
Journal:  Psychiatry Res       Date:  2013-07-26       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.